PM Slate: The IPO that broke the queue

SpaceX (SPCX) was supposed to be proof of concept. The largest IPO in history, a $1.77 trillion debut. Elon Musk briefly became the world's first trillionaire. For about a week, it looked like the AI era had found its public-market moment.

Then SPCX went from $225 to $153 in ten trading days. Not a crash, but a 32% drawdown from peak, in a stock most retail investors had just bought at the height of the hype cycle.

The damage wasn't just to SpaceX holders. It hit the IPO queue behind it. Today, that queue got visibly shorter.

OpenAI is leaning toward delaying its public debut to 2027. Sam Altman won't accept a valuation below $1 trillion. The market, as of this morning, isn't sure it believes that number yet. So instead of listing, they're waiting.

This is the AI era's first real IPO hangover.

The Nasdaq is down over 1% on the day. The S&P 500 is off 0.75%. But the Russell 2000 is up 0.71%. 

When small caps and pharma outperform mega-cap tech on a Friday, that's rotation, not retreat. The money isn't leaving the market. It's leaving the AI premium trade. Quarter-end rebalancing is amplifying the move: fund managers trimming positions that ran hardest all spring.

The deeper read is that the S&P 500 is down 3% in June after surging through April and May. The Nasdaq has now logged four consecutive losing days, its worst run since February. The spring rally is consolidating. Whether it's digesting or unwinding will only become clear when Q2 earnings season opens in mid-July.

The New York Times dropped the story Thursday evening. OpenAI is now leaning toward delaying its IPO until 2027. The reason, barely disguised: SpaceX scared them.

Altman wants $1 trillion. His advisers presented two options: wait until 2027 and let the financials mature into that number, or accept a lower valuation and list faster. His answer, per a source close to him, was that any reduction from the trillion-dollar target was a "nonstarter."

The company has real revenue and the core product is embedded in enterprise workflows across most of the Fortune 500. But SpaceX had real revenue too. Profitable business, dominant launch platform, 5 million Starlink subscribers. It listed at $1.77 trillion. Two weeks later, it's trading around 30% below its intraday high, hovering near its listing price of $135.

The market's message to mega-cap AI is becoming legible. It will accept the thesis. It won't hold the price unconditionally.

The market signal? 

Anthropic, which also filed confidentially in June, is now the marquee AI listing of 2026 by default. Two trillion-dollar AI IPOs in the same year was always going to be a crowd. One has stepped back. That changes the math for the other.

For a sector that spent most of 2026 in the background, healthcare's week has been startling.

Eli Lilly (LLY) is up roughly 6% on the session. Johnson & Johnson (JNJ) gained 3% Thursday and extended again today. AbbVie (ABBV) added over 2%.

The reasons are layered. Healthcare underperformed the S&P 500 significantly since January while AI names ran, so the relative cheapness is real. It's defensive, offering stable cash flows and predictable earnings that don't depend on anyone building a new data center. And there's a quieter tailwind: the Hormuz reopening is a direct input cost story for pharma. Drug manufacturing is energy-intensive. Falling oil prices and lower shipping costs are margin-positive for the sector in ways that won't show up in this week's headlines but will show up in earnings calls.

The market signal? 

Healthcare's run looks early rather than late. If the rotation continues into earnings season, the sector that barely registered in the first half could be the defining trade of the second.

The CEO of this AI company (click here to get the name, 100% free) just issued a CODE RED in an internal memo…

Warning his employees that they’re dealing with a critical situation.

Another company executive even implied they might need a government bailout.

And now Jim Rickards is predicting this company is about to go bust, in a full-blown AI meltdown that could be 10 times bigger than Lehman Brothers. 

Click here to see the details and learn how to prepare.

But the tankers are moving again. Oil prices have continued falling Friday, Brent crude near $73 a barrel: its lowest since before the February airstrikes that started this whole mess.

In May, Brent posted its worst monthly decline since the COVID-19 pandemic..

This matters beyond energy stocks. The PCE data Wednesday came in broadly in line. The forward inflation trajectory now depends on whether oil holds here or reverses. Every dollar Brent falls takes pressure off shipping costs, manufacturing inputs, and eventually grocery shelves. The Fed's problem gets incrementally easier each week Hormuz stays open.

The risk: it doesn't stay open. A vessel attack was reported in the Gulf of Oman this morning. 

The market signal? Energy is pricing the deal as completely done. If it unravels, oil has a lot of ground to cover on the upside, and the Fed's summer window slams shut.

The last week of each quarter is structurally strange, and it has almost nothing to do with the news.

Large institutional funds like pension funds, endowments, and balanced mutual funds hold fixed allocations between stocks and bonds. A classic 60/40 portfolio. When equities surge through April and May, as they did, the stock portion grows beyond its target weight. To rebalance, the fund sells equities and buys bonds. Not because they're scared. Because the math says so.

This is quarter-end rebalancing. It is happening right now. And it's accelerating the selling pressure in the mega-cap tech names that already looked stretched.

The S&P 500 is down roughly 3% in June after a strong spring. How much of that is genuine AI-valuation reassessment and how much is mechanical rebalancing? Probably both, and separating them in real time is impossible. The practical read: the selling pressure that's defined this week has a mechanical component that largely completes by today's close. Monday's open will give a cleaner signal on where real sentiment sits.

We’ve found The Next Elon Musk… and what we believe to be the next Tesla.

It’s already racked up $26 billion in government contracts.

Peter Thiel just bet $1 Billion on it.

And you can get exposure — pre-IPO — through a 4-letter ticker symbol revealed in this free briefing.

Unlock the ticker now and get it completely free.

The IPO era just got complicated. SpaceX fell 32% from its peak in two weeks. OpenAI stepped back from the queue. Two of the most anticipated listings in market history, and the first one already has buyers underwater.